{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:14:55Z","timestamp":1780510495256,"version":"3.54.1"},"reference-count":30,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"unspecified","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2021-01348"],"award-info":[{"award-number":["2021-01348"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Liaison Committee","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100004590","name":"Central Norway Regional Health Authority","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004590","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Stockholm County Council","award":["2019-0248"],"award-info":[{"award-number":["2019-0248"]}]},{"name":"\u00c5ke Wiberg","award":["M18-0114"],"award-info":[{"award-number":["M18-0114"]}]},{"DOI":"10.13039\/100009123","name":"Norwegian University of Science and Technology","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100009123","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,10,26]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Serum prokineticin-1 (s-PROK1) in the second and third trimester of pregnancy is positively correlated to preeclampsia, intrauterine growth restriction (IUGR) and preterm delivery. Women with polycystic ovary syndrome (PCOS) are prone to these adverse pregnancy outcomes. However, the contribution of PROK1 to the development of pregnancy complications and the effect of metformin and hyperandrogenism on s-PROK1 in PCOS have not been studied previously.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>This work is a post hoc analysis of two prospective, randomised, placebo-controlled trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Pregnant women with PCOS were included from 11 study centres in Norway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>From 313\u2009women, 264 participated in the present study after exclusions due to dropouts or insufficient serum samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Women with PCOS were randomly administered with metformin or placebo, from first trimester to delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>s-PROK1 was analysed using ELISA at gestational week 19 and related to pregnancy complications, fasting insulin levels, homoeostatic model assessment for insulin resistance (HOMA-IR), testosterone, or androstenedione levels, metformin use, PCOS phenotype and hyperandrogenism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Maternal s-PROK1 in the second trimester did not predict pregnancy-induced hypertension, pre-eclampsia or late miscarriage\/preterm delivery in women with PCOS. However, s-PROK1 was lower in women who used metformin before inclusion, both in those randomised to metformin and to placebo, compared with those who did not. s-PROK1 was also lower in those who used metformin both at conception and during pregnancy compared with those who used metformin from inclusion or did not use metformin at all. s-PROK1 was lower in hyperandrogenic compared with normo-androgenic women with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Maternal s-PROK1 in the second trimester did not predict pregnancy complications in PCOS. Those who used metformin at conception and\/or during pregnancy had lower s-PROK1. PCOS women with hyperandrogenism exhibited lower s-PROK1 compared with normo-adrogenic phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03259919\">NCT03259919<\/jats:ext-link>\n                      and\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT00159536\">NCT00159536<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-073619","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T12:43:12Z","timestamp":1700570592000},"page":"e073619","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Maternal serum levels of prokineticin-1 related to pregnancy complications and metformin use in women with polycystic ovary syndrome: a post hoc analysis of two prospective, randomised, placebo-controlled trials"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct03259919","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00159536","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03259919","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00159536","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4659-9712","authenticated-orcid":false,"given":"Dorina","family":"Ujvari","sequence":"first","affiliation":[{"name":"Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden"},{"name":"Department of Microbiology, Tumor and Cell Biology; National Pandemic Centre; Centre for Translational Microbiome Research, Karolinska Institute, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Trouva","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica Lind\u00e9n","family":"Hirschberg","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden"},{"name":"Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Vanky","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway"},{"name":"Department of Gynaecology and Obstetrics, St Olav's University Hospital, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,21]]},"reference":[{"key":"2025121509373445000_13.11.e073619.1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew218"},{"key":"2025121509373445000_13.11.e073619.2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep399"},{"key":"2025121509373445000_13.11.e073619.3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2217\/WHE.09.39","article-title":"Polycystic ovary syndrome, obesity and reproductive implications","volume":"5","author":"Hirschberg","year":"2009","journal-title":"Womens Health (Lond)"},{"key":"2025121509373445000_13.11.e073619.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509283331307"},{"key":"2025121509373445000_13.11.e073619.5","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2025121509373445000_13.11.e073619.6","doi-asserted-by":"publisher","DOI":"10.1210\/er.2015-1018"},{"key":"2025121509373445000_13.11.e073619.7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032012"},{"key":"2025121509373445000_13.11.e073619.8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/hmbci-2015-0040","article-title":"Prokineticins in central and peripheral control of human reproduction","volume":"24","author":"Traboulsi","year":"2015","journal-title":"Horm Mol Biol Clin Investig"},{"key":"2025121509373445000_13.11.e073619.9","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.591850","article-title":"The emerging role of the Prokineticins and Homeobox genes in the Vascularization of the Placenta: physiological and pathological aspects","volume":"11","author":"Alfaidy","year":"2020","journal-title":"Front Physiol"},{"key":"2025121509373445000_13.11.e073619.10","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/451906","article-title":"The multiple roles of EG-VEGF\/Prok1 in normal and pathological Placental angiogenesis","volume":"2014","author":"Alfaidy","year":"2014","journal-title":"Biomed Res Int"},{"key":"2025121509373445000_13.11.e073619.11","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0912"},{"key":"2025121509373445000_13.11.e073619.12","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E10-01-0059"},{"key":"2025121509373445000_13.11.e073619.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2008.00554.x"},{"key":"2025121509373445000_13.11.e073619.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-012-1141-z"},{"key":"2025121509373445000_13.11.e073619.15","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gaq014"},{"key":"2025121509373445000_13.11.e073619.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.08.029"},{"key":"2025121509373445000_13.11.e073619.17","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1111\/jcmm.14923","article-title":"Dihydrotestosterone potentiates insulin to up-regulate Prokineticin-1 in Decidualizing human endometrial Stromal cells","volume":"24","author":"Ujvari","year":"2020","journal-title":"J Cell Mol Med"},{"key":"2025121509373445000_13.11.e073619.18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/jcmm.13305","article-title":"Prokineticin 1 is up-regulated by insulin in Decidualizing human endometrial Stromal cells","volume":"22","author":"Ujvari","year":"2018","journal-title":"J Cell Mol Med"},{"key":"2025121509373445000_13.11.e073619.19","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey256"},{"key":"2025121509373445000_13.11.e073619.20","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh347"},{"key":"2025121509373445000_13.11.e073619.21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0853"},{"key":"2025121509373445000_13.11.e073619.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12958-022-00905-6","article-title":"Pregnancy, perinatal and childhood outcomes in women with and without Polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study","volume":"20","author":"Fornes","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"2025121509373445000_13.11.e073619.23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","article-title":"Use of metformin to treat pregnant women with Polycystic ovary syndrome (Pregmet2): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"L\u00f8vvik","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025121509373445000_13.11.e073619.24","doi-asserted-by":"publisher","DOI":"10.1530\/REP-18-0278"},{"key":"2025121509373445000_13.11.e073619.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70150-X"},{"key":"2025121509373445000_13.11.e073619.26","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2001.801107.x"},{"key":"2025121509373445000_13.11.e073619.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-6349.2004.00276.x"},{"key":"2025121509373445000_13.11.e073619.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-6349.2005.00493.x"},{"key":"2025121509373445000_13.11.e073619.29","doi-asserted-by":"crossref","DOI":"10.1186\/1757-2215-3-23","article-title":"Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with Polycystic ovary syndrome (PCOS): relationships with adverse outcomes","volume":"3","author":"Falbo","year":"2010","journal-title":"J Ovarian Res"},{"key":"2025121509373445000_13.11.e073619.30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1100"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-073619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:38:30Z","timestamp":1765820310000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-073619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,21]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/bmjopen-2023-073619"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-073619","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}